Sustained elevation of vasopressin plasma levels in healthy young men, but not in abstinent alcoholics, upon expectation of novelty.
The role of vasopressin (AVP) as a stress hormone in man is still a matter of controversy. Thus, the response of plasma AVP, among other hormones, to either intravenously injected human corticotropin releasing factor (hCRF, in the absence or presence of the opioid antagonist naloxone) or a combined 5-minute stress test was compared in healthy men (n = 10) and short-term abstinent alcoholics (n = 11), a group with recognized abnormalities of humoral stress parameters. Stimuli were applied blindly and in random order, one per day, in a 3-day experimental block. A second block using the same standardized protocol was carried out 12 weeks later. Alcoholics entered block I 8 days after the last ethanol ingestion. Up to block II, they were strictly controlled for abstinence. On each experimental day, subjects remained supine from 0700h until 1500h. Stimuli were applied alternatively at 1030h each day. Fourteen blood samples were drawn per day with simultaneous fluid substitution. There were no significant changes in plasma AVP as an acute response to any of the stimuli in either group or block. However, unexpectedly, controls had significantly higher basal AVP levels throughout block I as compared with block II without concomitant changes in plasma osmolality or blood pressure. Further analysis of the data revealed that the dramatically increased AVP levels of the five younger control subjects accounted for this difference. In fact, AVP levels in the five older healthy subjects and in all alcoholics remained low throughout the two blocks. Our data suggest that plasma AVP is continuously elevated in healthy young men upon anticipation of novelty. In contrast, healthy men of the older age group and early abstinent alcoholics seem to lack such a sustained AVP response.
Ehrenreich
H
H
Department of Psychiatry, Georg-August-University, Germany. ehrenreich@exmed1.dnet.gwdg.de
tom Dieck
K
K
Gefeller
O
O
Kaw
S
S
Schilling
L
L
Poser
W
W
Rüther
E
E
D000328:Adult; D000437:Alcoholism / Q000097:blood / Q000534:rehabilitation*; D001127:Arginine Vasopressin / Q000097:blood*; D001143:Arousal / Q000502:physiology*; D002940:Circadian Rhythm / Q000502:physiology; D003346:Corticotropin-Releasing Hormone; D004311:Double-Blind Method; D006801:Humans; D008297:Male; D008875:Middle Aged; D009270:Naloxone; D009292:Narcotic Antagonists; D012016:Reference Values; D013695:Temperance; D014882:Water-Electrolyte Balance / Q000502:physiology
D009292:Narcotic Antagonists; D001127:Arginine Vasopressin; D009270:Naloxone; D003346:Corticotropin-Releasing Hormone